|
Market Cap (17-May) $522,816,704 (439th) |
Close (30-Jun) $4.40 |
Volume (30-Jun) 565,229 |
Shortsold (5-May) 2,410,503 (2.97%) (86th) |
|
52w High $7.31 |
52w Low $3.74 |
P/E 285.71 |
EPS -1.56 |
MYX released this announcement to the ASX on 27 February 2023, 13:24. The announcement is marked as price sensitive, and is 2 page(s) in length and 152.88kb in size.
You can view all announcements from MYX and see how they appear on a price chart on the announcements page.
At the date of this announcement, MYX was 4.543% short sold according to ASIC data. It was ranked the 39th most shorted stock on the ASX. It remains ranked 86th as of the latest reported data (05 May 2025).
| Other Recent Announcements from MYX | |
|---|---|
| Notification of cessation of securities - MYX | 30 June 2023, 16:11 |
| Update - Notification of buy-back - MYX | 30 June 2023, 8:19 |
| Update - Notification of buy-back - MYX | 29 June 2023, 8:20 |
| Mayne Pharma announces sale of US retail generics business | 27 February 2023, 13:24 |
| Trading Halt | 27 February 2023, 10:30 |
| Pause in Trading | 27 February 2023, 9:56 |
| MYX signs license & supply agreement for generic Oracea | 24 February 2023, 8:05 |
You must be logged in to post a reply.
Mayne Pharma Group 